Register for our free email digests:
Latest From Scrip Team
Coronavirus Update: AstraZeneca’s Vaccine Trials Cleared To Restart In the US, J&J Prepares To Restart Its Vaccine Study
Two potential COVID-19 vaccine trials from AstraZeneca and Johnson & Johnson are set to resume in the US following temporary pauses due to safety concerns. Data from both could come later this year.
Coronavirus Update: Gilead's Veklury Gets Full FDA Approval, Roche Partners With Atea
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
Executives On The Move: New CEOs at Topas Therapeutics, Lumeda And WntResearch
Diffusion Pharmaceuticals and WPD Pharmaceuticals get new chief medical officers.
Coronavirus Update: Human Vaccine Challenge Study Gains UK Backing
The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.
Executives On The Move: CEOs Named At Kaleido Biosciences, DewPoint Therapeutics And WntResearch AB
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.
Coronavirus Update: No Mortality Gains From Remdesivir In WHO Trial, Gilead Questions Results
Plus Sanofi and Translate Bio release preclinical data from their COVID-19 vaccine candidate, another entrant to the now crowded mRNA vaccine field.